Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pharmala Biotech Holdings Inc. (MDMA.CN)

Pharmala Biotech Holdings Inc. (MDMA.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pharmala Biotech Holdings Inc. 1 Adelaide Street East Suite 801 Toranto ON M5C 2V9 CAN

https://www.pharmala.ca P: 855-444-6362

Sector:

N/A

Description:

Pharmala Biotech Holdings Inc is focused on manufacturing and sales of MDMA and MDXX Active Pharmaceutical Ingredients (API) for use in clinical research. Its drug API is manufactured and encapsulated under GMP conditions. The company generates revenue from the sale of tablets and raw MDMA and MDXX compounds/formulations and royalties from licensing of its IP.

Key Statistics

Overview:

Market Capitalization, $K 10,889
Shares Outstanding, K 108,887
Annual Sales, $ 605 K
Annual Net Income, $ -2,175 K
Last Quarter Sales, $ 206 K
Last Quarter Net Income, $ -410 K
60-Month Beta 0.38
% of Institutional Shareholders 3.61%

Growth:

1-Year Return -65.00%
3-Year Return 233.33%
5-Year Return 0.00%

Per-Share Information:

Most Recent Earnings -0.01 on 12/23/25
Next Earnings Date N/A
Earnings Per Share ttm -0.02
EPS Growth vs. Prev Year 680.94%
Dividend Payout Ratio 0.00%

MDMA.CN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -98.51%
Return-on-Assets % -69.87%
Profit Margin % -359.25%
Debt/Equity N/A
Price/Sales 13.72
Price/Book 4.59
Book Value/Share 0.02
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar